NCT01716130View on ClinicalTrials.gov

Acceptability of Fluzone Intradermal Vaccine to Patients and Vaccine Administrators

CompletedOBSERVATIONAL
Enrollment

249

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

November 30, 2011

Study Completion Date

November 30, 2011

Conditions
Patient Response to Fluzone ID Vaccine
Trial Locations (1)

94592

Touro University California, Vallejo

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

Touro University, California

OTHER

NCT01716130 - Acceptability of Fluzone Intradermal Vaccine to Patients and Vaccine Administrators | Biotech Hunter | Biotech Hunter